FDA issued draft guidance aimed at boosting generic drug competition
PoliticoPRO: By Sarah Owermohle
The FDA released draft guidance today aimed at boosting generic drug competition by clarifying manufacturers must disclose whether approved products...
CMS Seeks Comment on SNF Healthcare-Associated Infections Measures
The Centers for Medicare & Medicaid Services (CMS) Skilled Nursing Facility (SNF) Quality Reporting Program (QRP) is seeking input on measure specifications for Healthcare-Associated...
FEMA extends funding for eligible COVID-19 costs, issues advisory on medical staffing requests
President Biden yesterday extended through Dec. 31, 2021, 100% federal reimbursement through the Federal Emergency Management Agency’s Public Assistance Program for eligible costs to safely reopen...
Home Health Final Rule is Available for Inspection
On October 31st, CMS Finalized Calendar Year 2020 Payment and Policy Changes for Home Health Agencies and Calendar Year 2021 Home Infusion Therapy Benefit. The...
Major Updates – COVID-19
The Federal Emergency Management Agency (FEMA) has created a webpage to help the public distinguish between rumors and facts regarding the response to coronavirus...
CDC Issues New Masking Guidance for Vaccinated Individuals
The United States Center for Disease Control (CDC) has updated guidance for fully vaccinated people given new evidence on the B.1.617.2 (Delta) variant currently...
Farm bill deliberations shift to the Senate
With hopes of getting a farm bill by summer’s end, the Senate is moving forward with “bipartisan” legislation with S. 3042. Action on wide...
Anthem agrees to pay $16M for data breach
Anthem, the second largest health insurer in the nation, has agreed to pay the Department of Health and Human Services a record $16 million...
Tell Congress to “Get Real on Ratios” in Nursing Homes
The Center for Medicare and Medicaid Services (CMS) is poised to issue a rule imposing a federal minimum staffing mandate on nursing homes. We...
FDA approves powerful new opioid amid controversy
The Food and Drug Administration on Nov. 2 approved a new form of an extremely potent opioid, Dsuvia, just weeks after the chairman of...
